The total U.S. weight loss market is estimated to have grown to a historic peak of $90 billion in 2023, boosted by soaring sales of the popular prescription GLP-1 weight loss drugs. This is a major paradigm shift toward medical programs, and a major challenge for competing commercial diet companies, which lost $1+ billion in revenues since 2022.

Obstructive sleep apnea (OSA) affects roughly one out of every five people in the United States and it is estimated that 85% of people suffering from OSA are underdiagnosed (Santilli, et al., 2021).

The U.S. medical spas industry has more than tripled in size (in terms of revenue) since 2012, and was worth $17.5 billion in 2022. The COVID-19 pandemic actually boosted this business, as consumers in Zoom meetings viewed their facial faults and decided to correct them.

The survival rate of breast cancer has improved significantly over the last decade, shifting the focus of treatment towards quality of life, as opposed to simply survival. Breast cancer treatment typically consists of surgery, radiation therapy and/or medicines. A common procedure many breast cancer patients undergo is a mastectomy.

In the realm of medical diagnostics, technological advancements are often the catalysts that reshape the landscape. A prime example of this phenomenon is the rapid evolution of minimal residual disease (MRD) testing, a technique used to detect and quantify the small number of cancer cells that remain in a patient's body after treatment.

According to statistical data from the World Cancer Research Fund (WCRF) International, the incidence of cancer is increasing, especially, in countries with a low Human Development Index (HDI).

Active pharmaceutical ingredients (APIs) are active ingredients or substances that produce a positive health effect on the patient to cure a specific condition or disease. Some medications, like combination therapy, contain several APIs that may work differently or address various symptoms. Hence, APIs are of great importance in both pharmaceutical and biopharmaceutical industries for drug and therapeutics manufacturing.

The tide has turned to a greater focus on medical weight loss programs, many of which are now using the new obesity drugs. The big story of 2022 has been the soaring demand for new drugs such as Wegovy, Ozempic, and Saxenda, with more new drugs coming soon.

The biopharmaceutical sector is one of the most innovative industries in the world that has contributed significantly to developing novel drugs and vaccines for the treatment, prevention, and diagnosis of various diseases and disorders, such as cancer, neurological diseases, and metabolic disorders.

Preventive vaccines are administered to a person who is not affected by a targeted infection to induce the production of antibodies and strengthen the immune response to protect the person from future infections.